(ORGO) – Company Press Releases
-
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
-
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
-
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
-
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
-
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
-
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results
-
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
-
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS
-
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
-
Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance
-
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023
-
Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth
-
Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results
-
Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors
-
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
-
Organogenesis Applauds Findings from the Office of Inspector General
-
Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
-
Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance
-
Organogenesis Reports Positive Interim Analysis of Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
-
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023
-
Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference
-
Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results
-
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022
-
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
-
Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution
-
Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results
-
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022
-
Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results
-
Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors
-
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 Conference
-
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
-
Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business Journal
-
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference
-
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Guidance
-
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
-
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February
-
FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline – ORGO
-
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Revance, Paysafe, Organogenesis, and Cloopen Group and Encourages Investors to Contact
-
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Meta Materials, Paysafe, Organogenesis, and Marathon Digital and Encourages Investors to Contact the Fi
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sleep Number, Revance, Paysafe, and Organogenesis and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alfi, Berkeley Lights, Organogenesis, and Paysafe and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playtika, Alfi, Berkeley Lights, and Organogenesis and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Organogenesis, Paysafe, Revance Therapeutics, and Cloopen Group and Encourages Investors to Contact the
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alfi, Berkeley Lights, and Organogenesis and Encourages Investors to Contact the Firm
-
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
-
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
Back to ORGO Stock Lookup
